A qualitative research exploring the experiences of patients receiving immune checkpoint inhibitors for advanced lung cancer

被引：0
|
作者：
Yunxia Hou
Yingge Hou
Jing Li
Lijuan Yu
Ling Yan
机构：
[1] Key Laboratory of Cancer Prevention and Therapy,Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer
[2] Tianjin Medical University,undefined
来源：
Supportive Care in Cancer | 2023年 / 31卷
关键词：
Immune checkpoint inhibitors; Stage IV non-small cell lung cancer; Quality of life; Qualitative research; Supportive care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A qualitative research exploring the experiences of patients receiving immune checkpoint inhibitors for advanced lung cancer
    Hou, Yunxia
    Hou, Yingge
    Li, Jing
    Yu, Lijuan
    Yan, Ling
    SUPPORTIVE CARE IN CANCER, 2023, 31 (08)
  • [2] Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors: Antibiotics immune checkpoint inhibitors in advanced NSCLC
    Schett, Anne
    Rothschild, Sacha I.
    Curioni-Fontecedro, Alessandra
    Kraehenbuehl, Stephan
    Frueh, Martin
    Schmid, S.
    Driessen, Christoph
    Joerger, Markus
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (01) : 121 - 131
  • [3] Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors
    Chen, Xiuqiong
    Li, Zhaona
    Zhou, Jing
    Wei, Qianhui
    Wang, Xinyue
    Jiang, Richeng
    PEERJ, 2022, 10
  • [4] The impact of cancer pain on survival of lung cancer patients receiving immune checkpoint inhibitors
    Wang, S.
    Ye, Z-H.
    Zhang, J.
    Lee, T. T. L.
    Wai, A. K. C.
    Kong, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S890 - S890
  • [5] Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Fujita, Kohei
    Yamamoto, Yuki
    Kanai, Osamu
    Okamura, Misato
    Hashimoto, Masayuki
    Nakatani, Koichi
    Sawai, Satoru
    Mio, Tadashi
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (05):
  • [6] Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Fujita, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [7] Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitorsAntibiotics immune checkpoint inhibitors in advanced NSCLC
    Anne Schett
    Sacha I. Rothschild
    Alessandra Curioni-Fontecedro
    Stephan Krähenbühl
    Martin Früh
    S. Schmid
    Christoph Driessen
    Markus Joerger
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 121 - 131
  • [8] Analysis of immune checkpoint inhibitors for advanced non-small cell lung cancer in patients receiving antacids
    Isono, Taisuke
    Furuno, Hajime
    Onodera, Yoko
    Maruyama, Tomoya
    Takeuchi, Yuki
    Kojima, Ayaka
    Nishida, Takashi
    Kobayashi, Yoichi
    Ishiguro, Takashi
    Takaku, Yotaro
    Kurashima, Kazuyoshi
    Kagiyama, Naho
    RESPIRATORY INVESTIGATION, 2024, 62 (06) : 951 - 959
  • [9] Hyperprogression in Patients With Cancer Receiving Immune Checkpoint Inhibitors
    Sehgal, Kartik
    JAMA NETWORK OPEN, 2021, 4 (03)
  • [10] The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors
    Perrone, Fabiana
    Favari, Elda
    Maglietta, Giuseppe
    Verze, Michela
    Pluchino, Monica
    Minari, Roberta
    Sabato, Roberto
    Mazzaschi, Giulia
    Ronca, Annalisa
    Rossi, Alessandra
    Cortellini, Alessio
    Pecci, Federica
    Cantini, Luca
    Bersanelli, Melissa
    Quaini, Federico
    Tiseo, Marcello
    Buti, Sebastiano
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2127 - 2135
12345